Retinoblastoma

I accept Terms and Conditions and agree to receive marketing letters that can be interesting for me.

Disease description

Retinoblastoma is a malignant tumor of the retina that commonly affects children under the age of two. Approximately 25% of patients have bilateral hereditary involvement, 15% develop unilateral cancer, and 60% experience unilateral non-hereditary tumors.

The five-year survival rate for patients diagnosed at an early stage is 90%. However, in hereditary retinoblastoma, the recurrence rate doubles.

Symptoms indicating the need for diagnosis and treatment

  • Leukocoria (white pupillary reflex) — a white reflection from the retina that appears as a bright spot in the eye
  • Strabismus (crossed eyes)
  • Visual impairment
  • In late stages: orbital tumor, headaches, vomiting
Please complete a brief questionnaire – this will help us better assess your situation and offer the most suitable solution.
Start
Are you planning a regular health check-up?
No current diagnosis? Need diagnostic testing?
Existing diagnosis with unsatisfactory treatment results?
Interested in receiving medical care abroad?
Interested in an online second opinion from a foreign doctor?
Your name
E-mail
Phone number (with country code)
Something went wrong 🙁
We have received your request
A specialist will contact you within an hour.

Diagnostic and treatment methods

Diagnostic

  • Ultrasound examination
  • Computed tomography (CT) or magnetic resonance imaging (MRI)
  • Optical coherence tomography (OCT)
  • Bone scanning
  • Bone marrow biopsy
  • Lumbar puncture (collection of cerebrospinal fluid)

Treatment

In advanced unilateral cancer, leading European hospitals use enucleation and chemotherapy. For bilateral tumors, treatment includes photocoagulation, intra-arterial chemotherapy, and cryotherapy. For more on how pediatric oncology differs from adult oncology and which treatment approaches are most effective today, see our article on pediatric oncology.

Innovations in global clinics

World-class medical centers apply molecular genetic testing, conducted in two stages. This analysis identifies the genetic cause of retinoblastoma (detecting damaged DNA) and enables the selection of targeted, etiotropic treatment.

Medical treatment worldwide
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.